Skip to main content
← Companies
CLNN

Clene Inc.

Data as of Sep 17, 2026
CLNN
CIK 1822791Pharmaceutical Preparations

Lobbying

$555,000 in reported federal lobbying spend across 17 quarterly filings, most recently Aug 3, 2026. Amounts are the sums companies and their registrants report on Lobbying Disclosure Act filings; a filing that covers several issues counts its full amount under each.

Spend by issue

  • Health Issues$205K9 filings
  • Energy/Nuclear$200K4 filings
  • Medical/Disease Research/Clinical Labs$150K1 filing

Latest filings, Jan 2026 onward

FiledRegistrant and subjectAmount
Aug 3, 2026
LOT SIXTEEN LLC for CLENERA LLC
Energy/Nuclear Federal permitting processes; renewable energy development and advancement
$60,000
Jul 20, 2026
CAPITOL HILL CONSULTING GROUP for CLENE NANOMEDICINE
Health Issues Issues related to accelerated approval.
$0
Jul 17, 2026
LOT SIXTEEN LLC for CLENERA LLC
Energy/Nuclear Federal permitting processes
$60,000
Apr 21, 2026
CAPITOL HILL CONSULTING GROUP for CLENE NANOMEDICINE
Health Issues Issues related to accelerated approval.
$0
Apr 20, 2026
LOT SIXTEEN LLC for CLENERA LLC
Energy/Nuclear Federal permitting processes
$60,000
Jan 20, 2026
CAPITOL HILL CONSULTING GROUP for CLENE NANOMEDICINE
Health Issues Issues related to accelerated approval.
$20,000

Data: Quiver Quantitative, FEC, Senate Lobbying Disclosure Act filings, USAspending, congressional periodic transaction reports. Records are matched to Clene Inc. through its SEC registration (CIK 1822791) and tickers CLNN.

As of: lobbying filings through Aug 3, 2026. Snapshot rebuilt Sep 17, 2026.

Holdings values are estimates from disclosed ranges. Donation coverage for a cycle begins with the first month loaded, so earlier months may still be missing.